Initiation, adherence to AIs low for older women with DCIS

(HealthDay)—For older women with estrogen receptor (ER)-positive ductal carcinoma in situ (DCIS), initiation of aromatase inhibitors (AIs) and adherence to treatment are low, according to a study published online Oct. 25 in Cancer.

Breast Cancer

Initiation, adherence to AIs low for older women with DCIS

Cancers, Free Full-Text

Breast Cancer Treatment (PDQ®) - NCI

Cancers, Free Full-Text

Disparities Archives - Kaiser Permanente Division of Research

Frontiers Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management

Management of breast cancer: an overview for therapeutic radiographers, Journal of Radiotherapy in Practice

PDF) Tamoxifen Initiation After Ductal Carcinoma In Situ

Factors associated with adherence to medications for lowering breast cancer risk between female Medicare beneficiaries in Alabama and nationwide

PDF) Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II

Initiation of and adherence to tamoxifen and aromatase inhibitor therapy among elderly women with ductal carcinoma in situ - Zhao - 2017 - Cancer - Wiley Online Library

Adjuvant Hormonal Therapy Adherence in Breast Cancer - BCTT